BlueStone Venture Partners
Venture capitalTucson · Seed–Series B · 2 people tracked
Investment thesis
BlueStone Venture Partners is a venture capital firm investing in early-stage life science companies focused on medical devices, health IT, advanced materials, and molecular diagnostics. The firm provides capital and strategic support to B2B companies in these sectors.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does BlueStone Venture Partners invest at?
- BlueStone Venture Partners invests at the Seed, Series A, Series B stages.
- What is BlueStone Venture Partners's typical check size?
- BlueStone Venture Partners typically writes checks of $250K – $1M.
- What sectors does BlueStone Venture Partners focus on?
- BlueStone Venture Partners focuses on Biotech, Enterprise Software, Healthtech, Medical Devices, New Materials.
- Where is BlueStone Venture Partners located?
- BlueStone Venture Partners is headquartered in Tucson, US.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Mohr Davidow Ventures is a venture capital firm that invests across energy and materials, Internet services, life sciences, semiconductors, software, and systems sectors.
IDG Capital is a private equity firm that has invested in venture capital opportunities in China since 1993. The firm operates across multiple investment stages and geographic markets.